Cargando…
SARS-CoV-2 Binding and Neutralization Properties of Peptides Derived from N-Terminus of Human ACE2
The binding properties of synthetic and recombinant peptides derived from N-terminal part of ACE2, the main receptor for SARS-CoV-2, were evaluated. Additionally, the ability of these peptides to prevent virus entry in vitro was addressed using both pseudovirus particles decorated with the S protein...
Autores principales: | Astrakhantseva, Irina V., Ershova, Alina E., Chuvpilo, Sergei A., Kruglova, Natalia A., Ishmukhametov, Aydar A., Drutskaya, Marina S., Kozlovskaya, Liubov I., Nedospasov, Sergei A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10179272/ https://www.ncbi.nlm.nih.gov/pubmed/37175976 http://dx.doi.org/10.3390/ijms24098269 |
Ejemplares similares
-
Will Peptides Help to Stop COVID-19?
por: Krut’, Viktoriya G., et al.
Publicado: (2022) -
Antibodies to the N-Terminal Domain of Angiotensin-Converting Enzyme (ACE2) That Block Its Interaction with SARS-CoV-2 S Protein
por: Krut, V. G., et al.
Publicado: (2021) -
On Immunological Studies at Sirius University of Science and Technology
por: Astrakhantseva, I. V., et al.
Publicado: (2023) -
TNF Neutralization Results in the Delay of Transplantable Tumor Growth and Reduced MDSC Accumulation
por: Atretkhany, Kamar-Sulu N., et al.
Publicado: (2016) -
Peptide Inhibitors of the Interaction of the SARS-CoV-2 Receptor-Binding Domain with the ACE2 Cell Receptor
por: Bibilashvili, R. Sh., et al.
Publicado: (2021)